These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 6398430)

  • 1. A comparative trial of desferrioxamine and hydroxychloroquine for treatment of porphyria cutanea tarda in alcoholic patients.
    Marchesi L; Di Padova C; Cainelli T; Reseghetti A; Di Padova F; Rovagnati P; Cantoni L
    Photodermatol; 1984 Dec; 1(6):286-92. PubMed ID: 6398430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxychloroquine treatment of porphyria cutanea tarda.
    Malkinson FD; Levitt L
    Arch Dermatol; 1980 Oct; 116(10):1147-50. PubMed ID: 7425660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porphyria cutanea tarda: comparison of cases precipitated by alcohol and estrogens.
    Haberman HF; Rosenberg F; Menon IA
    Can Med Assoc J; 1975 Oct; 113(7):653-5. PubMed ID: 1181022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Iron metabolism and chloroquine phosphate therapy in porphyria cutanea tarda].
    Köstler E; Pollack P; Seebacher C; Riedel H
    Z Hautkr; 1990 Nov; 65(11):1030-2, 1035. PubMed ID: 2080653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin as treatment of haemodialysis-related porphyria cutanea tarda.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Bianco L; Salvadeo A; Barosi G
    Nephrol Dial Transplant; 1992; 7(5):438-42. PubMed ID: 1321381
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine].
    Seubert S; Seubert A; Stella AM; Guzman H; Batlle A
    Z Hautkr; 1990 Mar; 65(3):223-5. PubMed ID: 2339575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine versus phlebotomy in the treatment of porphyria cutanea tarda.
    Cainelli T; Di Padova C; Marchesi L; Gori G; Rovagnati P; Podenzani SA; Bessone E; Cantoni L
    Br J Dermatol; 1983 May; 108(5):593-600. PubMed ID: 6849826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion.
    Rocchi E; Gibertini P; Cassanelli M; Pietrangelo A; Borghi A; Pantaleoni M; Jensen J; Ventura E
    Br J Dermatol; 1986 May; 114(5):621-9. PubMed ID: 3718853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experiences with iron elimination therapy in porphyria cutanea tarda].
    Haneke E; Schwartze G
    Z Gesamte Inn Med; 1971 Nov; 26(22):710-6. PubMed ID: 5141034
    [No Abstract]   [Full Text] [Related]  

  • 10. Phlebotomy treatment of porphyria cutanea tarda.
    Lundvall O
    Acta Derm Venereol Suppl (Stockh); 1982; 100():107-18. PubMed ID: 6962627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver iron overload and desferrioxamine treatment of porphyria cutanea tarda.
    Rocchi E; Cassanelli M; Borghi A; Paolillo F; Pradelli M; Pellizzardi S; Vezzosi A; Gallo E; Baccarani Contri M; Ventura E
    Dermatologica; 1991; 182(1):27-31. PubMed ID: 2013352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic and pathogenetic aspects of porphyria cutanea tarda].
    Köstler E; Seebacher C; Riedel H; Kemmer C
    Hautarzt; 1986 Apr; 37(4):210-6. PubMed ID: 3009356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desferrioxamine in the treatment of porphyria cutanea tarda: ineffectiveness of intramuscular administration.
    Muñoz JJ; Garcia-Cabezas J; Martinez-Verano J; Perez-Oteyza C; Enriquez de Salamanca R
    J Dermatol; 1990 May; 17(5):329-31. PubMed ID: 2380437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of hemodialysis-related porphyria cutanea tarda with deferoxamine.
    Stockenhuber F; Kurz R; Grimm G; Moser G; Balcke P
    Nephron; 1990; 55(3):321-4. PubMed ID: 2370933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyria cutanea tarda: clinical and laboratory features.
    Sweeney GD; Jones KG
    Can Med Assoc J; 1979 Apr; 120(7):803-7. PubMed ID: 427687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of interferon and desferrioxamine on serum ferritin and hepatic iron concentrations in chronic hepatitis B.
    Bayraktar Y; Saglam F; Temizer A; Uzunalimodlu B; van Thiel DH
    Hepatogastroenterology; 1998; 45(24):2322-7. PubMed ID: 9951916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hemodialysis-related porphyria cutanea tarda with deferoxamine.
    Praga M; Enriquez de Salamanca R; Andres A; Nieto J; Oliet A; Perpiña J; Morales JM
    N Engl J Med; 1987 Feb; 316(9):547-8. PubMed ID: 3808000
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda.
    Rocchi E; Gibertini P; Cassanelli M; Pietrangelo A; Borghi A; Ventura E
    J Lab Clin Med; 1986 Jan; 107(1):36-42. PubMed ID: 3941293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Porphyria cutanea tarda: study of the changes in porphyrin metabolism during desferrioxamine therapy].
    Mazza U; Bianco G; Fiorina L; Prato V
    Boll Soc Ital Biol Sper; 1965 Jan; 41(1):2-4. PubMed ID: 5875798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.